MedTrace Logo

Dermatological Assessment of Primary Dermal Irritability Accumulated and Sensitization

NCT04248556 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2021-05-10

No results posted yet for this study

Summary

This is a clinical study for health care product safety assessment. The research will be conducted with 92 subjects, aged 18 to 59 years. The product will be applied on the right and/or left back of the research participants for 3 consecutive weeks. After 10 days, will have another application of the same product, which will be removed in 48 hours. Medical evaluation will be available throughout the study to assess possible adverse events.

The objective of the study is to observe the effects of the application of the product on the skin and prove the absence of irritability and/or allergy.

Conditions

  • Sensitivity, Contact

Interventions

OTHER

Health care product

Health care product (gel) - to be applied on the participant's skin

Sponsors & Collaborators

  • Herbarium Laboratorio Botanico Ltda

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-09
Primary Completion
2021-04-17
Completion
2021-04-17

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04248556 on ClinicalTrials.gov